427
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Non-ionic surfactant based vesicular drug delivery system for topical delivery of caffeine for treatment of cellulite: design, formulation, characterization, histological anti-cellulite activity, and pharmacokinetic evaluation

, , , &
Pages 158-171 | Received 19 Jun 2017, Accepted 06 Sep 2017, Published online: 17 Oct 2017

References

  • Friedmann DP, Vick GL, Mishra V. Cellulite: a review with a focus on subcision. Clin Cosmet Investig Dermatol. 2017;10:17–23.
  • Rossi AM, Katz BE. A modern approach to the treatment of cellulite. Dermatol Clin. 2014;32:51–59.
  • Rossi AB, Vergnanini AL. Cellulite: a review. J Eur Acad Dermatol Venereol. 2000;14:251–262.
  • Khan MH, Victor F, Rao B, et al. Treatment of cellulite: Part I. Pathophysiology. J Am Acad Dermatol. 2010;62:361–370. quiz 371-2.
  • Bertin C, Zunino H, Pittet JC, et al. A double-blind evaluation of the activity of an anti-cellulite product containing retinol, caffeine, and ruscogenine by a combination of several non-invasive methods. J Cosmet Sci. 2001;52:199–210.
  • Vogelgesang B, Bonnet I, Godard N, et al. In vitro and in vivo efficacy of sulfo-carrabiose, a sugar-based cosmetic ingredient with anti-cellulite properties. Int J Cosmet Sci. 2011;33:120–125.
  • Naik A, Kalia YN, Guy RH. Transdermal drug delivery: overcoming the skin’s barrier function. Pharm Sci Technol Today. 2000;3:318–326.
  • Shakeel F, Ramadan W. Transdermal delivery of anticancer drug caffeine from water-in-oil nanoemulsions. Colloids Surf B Biointerfaces. 2010;75:356–362.
  • Cerqueira-Coutinho C, Dos Santos EP, Mansur CR. Niosomes as nano-delivery systems in the pharmaceutical field. Crit Rev Ther Drug Carrier Syst. 2016;33:195–212.
  • Muzzalupo R, Tavano L, Lai F, et al. Niosomes containing hydroxyl additives as percutaneous penetration enhancers: effect on the transdermal delivery of sulfadiazine sodium salt. Colloids Surf B Biointerfaces. 2014;123:207–212.
  • Liang R, Chen L, Yokoyama W, et al. Niosomes consisting of Tween-60 and cholesterol improve the chemical stability and antioxidant activity of (−)-epigallocatechin gallate under intestinal tract conditions. J Agric Food Chem. 2016;64:9180–9188.
  • Choi MJ, Maibach HI. Liposomes and niosomes as topical drug delivery systems. Skin Pharmacol Physiol. 2005;18:209–219.
  • Tabbakhian M, Tavakoli N, Jaafari MR, et al. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm. 2006;323:1–10.
  • El-Sayed MM, Hussein AK, Sarhan HA, et al. Flurbiprofen-loaded niosomes-in-gel system improves the ocular bioavailability of flurbiprofen in the aqueous humor. Drug Dev Ind Pharm. 2017;43:902–910.
  • Kamboj S, Saini V, Bala S. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement. Sci World J. 2014;2014:959741.
  • Ramanathan S, Block LH. The use of chitosan gels as matrices for electrically-modulated drug delivery. J Control Release. 2001;70:109–123.
  • Cazares-Delgadillo J, Ganem-Rondero A, Merino V, et al. Controlled transdermal iontophoresis for poly-pharmacotherapy: simultaneous delivery of granisetron, metoclopramide and dexamethasone sodium phosphate in vitro and in vivo. Eur J Pharm Sci. 2016;85:31–38.
  • Gore DM, O’Brart DP, French P, et al. A comparison of different corneal iontophoresis protocols for promoting transepithelial riboflavin penetration. Invest Ophthalmol Vis Sci. 2015;56:7908–7914.
  • Crevenna R, Burian A, Oesterreicher Z, et al. Iontophoresis driven concentrations of topically administered diclofenac in skeletal muscle and blood of healthy subjects. Eur J Clin Pharmacol. 2015;71:1359–1364.
  • Inoue T, Sugiyama T, Ikoma T, et al. Drug delivery and transmission of lidocaine using iontophoresis in combination with direct and alternating currents. J Med Dent Sci. 2016;63:71–77.
  • Sezgin-Bayindir Z, Yuksel N. Investigation of formulation variables and excipient interaction on the production of niosomes. AAPS PharmSciTech. 2012;13:826–835.
  • Mokhtar M, Sammour OA, Hammad MA, et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. Int J Pharm. 2008;361:104–111.
  • Ezzat SM, Salama MM, ElMeshad AN, et al. HPLC-DAD-MS/MS profiling of standardized rosemary extract and enhancement of its anti-wrinkle activity by encapsulation in elastic nanovesicles. Arch Pharm Res. 2016;39:912–925.
  • Ruckmani K, Sankar V. Formulation and optimization of Zidovudine niosomes. AAPS PharmSciTech. 2010;11:1119–1127.
  • Kamble B, Talreja S, Gupta A, et al. Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes. Nanomedicine. 2013;8:1295–1305.
  • Bragagni M, Mennini N, Furlanetto S, et al. Development and characterization of functionalized niosomes for brain targeting of dynorphin-B. Eur J Pharm Biopharm. 2014;87:73–79.
  • Arpan C, Vineetkumar P, Manish N, et al. A novel lipid-based oral drug delivery system of Nevirapine. Int J PharmTech Res. 2011;3:1159–1168.
  • Coviello T, Trotta AM, Marianecci C, et al. Gel-embedded niosomes: preparation, characterization and release studies of a new system for topical drug delivery. Colloids Surf B Biointerfaces. 2015;125:291–299.
  • Jain S, Vyas SP. Mannosylated niosomes as carrier adjuvant system for topical immunization. J Pharm Pharmacol. 2005;57:1177–1184.
  • Nasr A, Gardouh A, Ghorab M. Novel solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of olmesartan medoxomil: design, formulation, pharmacokinetic and bioavailability evaluation. Pharmaceutics. 2016;8:2–29.
  • Abdelbary AA, AbouGhaly MH. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box–Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int J Pharm. 2015;485:235–243.
  • Huang JF, Sung KC, Hu OY, et al. The effects of electrically assisted methods on transdermal delivery of nalbuphine benzoate and sebacoyl dinalbuphine ester from solutions and hydrogels. Int J Pharm. 2005;297:162–171.
  • Ruckmani K, Jayakar B, Ghosal SK. Nonionic surfactant vesicles (niosomes) of cytarabine hydrochloride for effective treatment of leukemias: encapsulation, storage, and in vitro release. Drug Dev Ind Pharm. 2000;26:217–222.
  • El-Ridy MS, Abdelbary A, Essam T, et al. Niosomes as a potential drug delivery system for increasing the efficacy and safety of nystatin. Drug Dev Ind Pharm. 2011;37:1491–1508.
  • El-Nabarawi MA, Bendas ER, El Rehem RT, et al. Transdermal drug delivery of paroxetine through lipid-vesicular formulation to augment its bioavailability. Int J Pharm. 2013;443:307–317.
  • Blaise S, Roustit M, Millet C, et al. Cathodal iontophoresis of treprostinil and iloprost induces a sustained increase in cutaneous flux in rats. Br J Pharmacol. 2011;162:557–565.
  • Velasco MV, Tano CT, Machado-Santelli GM, et al. Effects of caffeine and siloxanetriol alginate caffeine, as anticellulite agents, on fatty tissue: histological evaluation. J Cosmet Dermat. 2008;7:23–29.
  • Bancroft JDGM. Theory and practice of histological technique. 5th ed. London (UK): Churchil Livingston; 2002.
  • Baillie AJ, Florence AT, Hume LR, et al. The preparation and properties of niosomes-non-ionic surfactant vesicles. J Pharm Pharmacol. 1985;37:863–868.
  • Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm. 2005;300:95–101.
  • Sammour OA, Abu-Zaid SS, Abu-Selem ME, et al. Formulation and evaluation of Timolol maleate loaded niosomes as an ocular drug delivery system. Bull Fac Pharm Cairo Univ. 2004;42:249–262.
  • Lingan MA, Sathali AAH, Kumar MRV, et al. Formulation and evaluation of topical drug delivery system containing clobetasol propionate niosomes. Sci Revs Chem Commun. 2011;1:7–17.
  • Gad HA, Kamel AO, Sammour OA, et al. Vesicular powder as carrier for doxycycline hydrochloride and metronidazole combination therapy. Pharm Dev Technol. 2014;19:755–768.
  • Patel KK, Kumar P, Thakkar HP. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel. AAPS PharmSciTech. 2012;13:1502–1510.
  • Guinedi AS, Mortada ND, Mansour S, et al. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005;306:71–82.
  • El-Samaligy MS, Afifi NN, Mahmoud EA. Increasing bioavailability of silymarin using a buccal liposomal delivery system: preparation and experimental design investigation. Int J Pharm. 2006;308:140–148.
  • Abdelbary G, El-Gendy N. Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech. 2008;9:740–747.
  • Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes)of sorbitan monoesters(Span 20,40,60 and 80)and a sorbitan trimester (Span 85). Int J Pharm. 1994;150:1–6.
  • Bendas ER, Tadros MI. Enhanced transdermal delivery of salbutamol sulfate via ethosomes. AAPS PharmSciTech. 2007;8:E107.
  • Bendas ER, Abdullah H, El-Komy MH, et al. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus. Int J Pharm. 2013;458:287–295.
  • El-Ridy MS, Abdelbary A, Nasr EA, et al. Niosomal encapsulation of the antitubercular drug, pyrazinamide. Drug Dev Ind Pharm. 2011;37:1110–1118.
  • Marwa A, Omaima S, Hanaa EL-G, et al. Preparation and in-vitro evaluation of diclofenac sodium niosomal formulations. Int J Pharm Sci Res. 2013;4:1757–1765.
  • Sankar V, Praveen C, Prasanth KG, et al. Formulation and evaluation of a proniosomes hydrocortisone gel in comparison with a commercial cream. Pharmazie. 2009;64:731–734.
  • Akhilesh D, Bini KB, Prabhakara P, et al. Development and characterization of non-ionic surfactant vesicles (niosomes) for oral delivery of lornoxicam. Int J Drug Deliv Res. 2012;4:147–154.
  • Faruk A, Singh G, Singh I, et al. Effect of drug concentration and permeation enhancer on iontophoretic transport of salbutamol sulphate in vitro. Int J Pharm Sci Nanotechnol. 2009;1:341–348.
  • Prasanthi D, Lakshmi PK. Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder. Int Braz J Urol. 2013;39:1–9.
  • Jain S, Chaudhari BH, Swarnakar NK. Preparation and characterization of niosomal gel for iontophoresis mediated transdermal delivery of isosorbide dinitrate. Drug Deliv Transl Res. 2011;1:309–321.
  • Liu W, Hu M, Liu W, et al. Investigation of the carbopol gel of solid lipid nanoparticles for the transdermal iontophoretic delivery of triamcinolone acetonide acetate. Int J Pharm. 2008;364:135–141.
  • Saleh AA-S, Ehab IT, Fahad MA-Q, et al. Evaluation of skin permeation and analgesic activity effects of carbopol lornoxicam topical gels containing penetration enhancer. Sci World J. 2014;2014:127495.
  • Oh SY, Jeong SY, Park TG, et al. Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer. J Control Release. 1998;51:161–168.
  • Mura P, Faucci MT, Bramanti G, et al. Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci. 2000;9:365–372.
  • Guy RH, Hadgraft J. The effect of penetration enhancers on the kinetics of percutaneous absorption. J Control Release. 1987;5:43–51.
  • Hori M, Maibach HI, Guy RH. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro. II: drug, vehicle, and enhancer penetration kinetics. J Pharm Sci. 1992;81:330–333.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.